Senior Medical Director, Global Med Affairs - Oncology

Johnson & Johnson Innovative Medicine•Raritan, NJ

1d•$164,000 - $282,900•Hybrid

About The Position

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine We are searching for the best talent for the Senior Medical Director-Oncology. Senior Medical Director-Oncology Global Medical Affairs, Multiple Myeloma Johnson & Johnson Oncology Global Medical Affairs, is recruiting for a Senior Medical Director for Multiple Myeloma. The preferred locations for this position are Bridgewater/Raritan, NJ however, remote work options may be considered on a case-by-case basis and if approved by the company. The Senior Medical Director Multiple Myeloma will be a member of the Global Medical Affairs team, leading the conduct of a global clinical study using the portfolio of compounds at J&J with the aim of building curative regimens for patients with multiple myeloma. The Senior Medical Director will work under the leadership of the Head of Myeloma and Plasma Cell Disorders, Global Medical Affairs, with the focus on leading a global medical affairs worldwide study. In addition, they will work closely with senior R&D Clinical Leaders of myeloma asset teams, working closely towards the goal of advancing the science and development of our myeloma compounds towards cure. They will be a standing member of the Global Medical Affairs Leadership team, Global Medical Affairs teams, and an ad hoc member of the myeloma clinical teams. The role requires a high-performing and energetic individual who demonstrates outstanding scientific knowledge applicable to hematology clinical research and the highest personal and ethical standards. Experience in running and the conduct of global or highly complex studies is a key area of expertise needed for this individual. The Senior Medical Director will also lead the development of protocol writing for and operational execution of this new multiple myeloma clinical studies. They will also be critically involved in external engagement of myeloma experts involved in this study, both supporting the scientific advocacy and scientific engagement of the medical community. Will participate in the interpretation and reporting of the results of the research, including any appropriate health authority interaction. They will evaluate scientific information and new ideas to assist in identifying new research opportunities. The Senior Medical Director Myeloma will also support other clinically related medical affairs activities across our myeloma portfolio around our pursuit of building regimens towards cure. They will also assess external clinical research proposals involving company products and manuscripts that are being prepared for publication. Will also act as a liaison between the company and clinical investigators. Importantly, they will lead the internal study working group for this global study, working with R&D cand regional Medical Affairs colleagues.

Requirements

A minimum of an advanced degree in medicine (i.e. M.D. or equivalent).
A trained Hematologist or Oncologist, or an individual with substantial previous experience in conducting hematology clinical studies is highly desired.
A minimum of 3 years’ experience in a clinical research position in an academically-based research institute or within the pharmaceutical industry is highly preferred.
Knowledge of basic and clinical cancer or hematology research and its application to drug development is required.
Experience specifically in multiple myeloma is highly desired, with experience working with myeloma experts in the medical community.
Good oral, written, and presentation skills (including report development) are essential.
Successful work experience in a matrix team environment is preferred.
Ability to lead a cross functional study team is required.
A strong commitment to hematology/oncology clinical research and the ability to work well within a team setting are essential.

Responsibilities

Leading the conduct of a global clinical study using the portfolio of compounds at J&J with the aim of building curative regimens for patients with multiple myeloma.
Leading a global medical affairs worldwide study.
Advancing the science and development of our myeloma compounds towards cure.
Leading the development of protocol writing for and operational execution of new multiple myeloma clinical studies.
Critically involved in external engagement of myeloma experts involved in this study, both supporting the scientific advocacy and scientific engagement of the medical community.
Participating in the interpretation and reporting of the results of the research, including any appropriate health authority interaction.
Evaluating scientific information and new ideas to assist in identifying new research opportunities.
Supporting other clinically related medical affairs activities across our myeloma portfolio around our pursuit of building regimens towards cure.
Assessing external clinical research proposals involving company products and manuscripts that are being prepared for publication.
Acting as a liaison between the company and clinical investigators.
Leading the internal study working group for this global study, working with R&D and regional Medical Affairs colleagues.